World's Best Scientists 2026 revealed!
Rachelle S. Doody

Rachelle S. Doody

D-Index & Metrics

Medicine

D-Index
96
Citations
58509
World Ranking
9471
National Ranking
127

Overview

Rachelle S. Doody is affiliated with Roche (Switzerland) and has a significant body of research focused on neurology and related biomedical fields. Their work engages primarily with the study and treatment of Alzheimer's disease, dementia, and neurological disorders, contributing extensively to the understanding of disease mechanisms and clinical trials.

Their research spans several main and subfields of study, including:

  • Medicine
  • Physiology
  • Psychiatry and Mental health
  • Neurology
  • Molecular Biology
  • Economics and Econometrics

Among the main topics addressed in their publications are:

  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Statistical Methods in Clinical Trials
  • Parkinson's Disease Mechanisms and Treatments
  • Functional Brain Connectivity Studies
  • Neurological disorders and treatments

Rachelle S. Doody has published in several frequent venues, including:

  • Alzheimer s & Dementia
  • The Journal of Prevention of Alzheimer s Disease
  • Nature Communications
  • Neurology
  • GeroScience

Recent notable papers by Doody include:

  • "Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease," 2020, Nature Communications
  • "Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study," 2020, Nature Communications
  • "A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease," 2021, Nature Medicine
  • "Trial of Prasinezumab in Early-Stage Parkinson's Disease," 2022, New England Journal of Medicine
  • "Functional brain architecture is associated with the rate of tau accumulation in Alzheimer's disease," 2020, Nature Communications

Frequent co-authors collaborating with Doody include:

  • John C. Morris
  • Paulo Fontoura
  • Clifford R. Jack
  • Geoffrey A. Kerchner
  • Lawrence S. Honig

Best Publications

  • Current concepts in mild cognitive impairment.

    Ronald C. Petersen;Rachelle Doody;Alexander Kurz;Richard C. Mohs

  • Memantine in Moderate-to-Severe Alzheimer's Disease

    Barry Reisberg;Rachelle Doody;Albrecht Stöffler;Frederick Schmitt

  • Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

    Ronald C. Petersen;Ronald G. Thomas;Michael Grundman;David Bennett

  • Practice parameter: Diagnosis of dementia (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology

    R. S. Doody;J. C. Stevens;C. Beck;R. M. Dubinsky

  • A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

    S. L. Rogers;M. R. Farlow;R. S. Doody;R. Mohs

  • Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

    RS Rachelle S. Doody;RG Ronald G. Rg Thomas;Martin Farlow;Takeshi Iwatsubo

  • A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

    Rachelle S. Doody;Rema Raman;Martin Farlow;Takeshi Iwatsubo

  • Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial

    R. A. Mulnard;C. W. Cotman;C. Kawas;C. H. Van Dyck

  • A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease

    Margaret J. Knapp;David S. Knopman;Paul R. Solomon;William W. Pendlebury

  • Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.

    Michael Grundman;Ronald C. Petersen;Steven H. Ferris;Ronald G. Thomas

  • Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

    Y. Iturria-Medina;R. C. Sotero;P. J. Toussaint;J. M. Mateos-Pérez

  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez

  • Donepezil Improves Cognition and Global Function in Alzheimer Disease A 15-Week, Double-blind, Placebo-Controlled Study

    Sharon L. Rogers;Rachelle S. Doody;Richard C. Mohs;Lawrence T. Friedhoff

  • Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study.

    Sid E. O’Bryant;Stephen C. Waring;C. Munro Cullum;James Hall

  • A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.

    S. Salloway;R. Sperling;S. Gilman;N.C.I. Fox

  • A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

    K. L. Davis;Leon J. Thal;E. R. Gamzu;C. S. Davis

  • Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study.

    L S Schneider;J T Olin;R S Doody;C M Clark

  • Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

    Rachelle S Doody;Svetlana I Gavrilova;Mary Sano;Ronald G Thomas

  • Validity and reliability of the Alzheimer's Disease Cooperative Study–Clinical Global Impression of Change.

    Lon S. Schneider;Jason T. Olin;Rachelle S. Doody;Christopher M. Clark

  • A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

    Richard C. Mohs;R. S. Doody;J. C. Morris;J. R. Ieni

Frequent Co-Authors

Paul J. Massman
Paul J. Massman University of Houston
Paul S. Aisen
Paul S. Aisen University of Southern California
John C. Morris
John C. Morris Washington University in St. Louis
Lon S. Schneider
Lon S. Schneider University of Southern California
Stephen Salloway
Stephen Salloway Brown University
Martin R. Farlow
Martin R. Farlow Indiana University
Steven H. Ferris
Steven H. Ferris New York University
Ronald C. Petersen
Ronald C. Petersen University of Pennsylvania
Ramon Diaz-Arrastia
Ramon Diaz-Arrastia University of Pennsylvania
Jeffrey Kaye
Jeffrey Kaye Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in healthcare but not sure if medical school is the right fit, there are several rewarding career paths to consider. Many students are turning to health information technology programs online to gain skills in managing patient data and healthcare systems. These roles are vital for hospitals and clinics and offer flexible career opportunities.

For those interested in the administrative side of medicine, cheapest medical billing and coding online courses provide a fast track to entering the healthcare field. Medical billing and coding professionals are essential for accurate patient records and insurance processes.

Nursing is another popular and respected pathway. Aspiring nurses can choose from a range of cheapest online np programs if they want to become nurse practitioners, or explore affordable nursing programs to launch or advance their nursing careers.

These online degrees and courses offer flexibility and cost-effective ways to start or grow your career in the healthcare sector, helping you make a meaningful impact without the commitment of medical school.

Best Scientists Citing Rachelle S. Doody

Trending Scientists